CY1107277T1 - Βενζισοξαζολες - Google Patents

Βενζισοξαζολες

Info

Publication number
CY1107277T1
CY1107277T1 CY20081100126T CY081100126T CY1107277T1 CY 1107277 T1 CY1107277 T1 CY 1107277T1 CY 20081100126 T CY20081100126 T CY 20081100126T CY 081100126 T CY081100126 T CY 081100126T CY 1107277 T1 CY1107277 T1 CY 1107277T1
Authority
CY
Cyprus
Prior art keywords
petrols
pharmaceuticals
reversible
preparation
fatty acid
Prior art date
Application number
CY20081100126T
Other languages
English (en)
Inventor
Joachim Nozulak
Hans O Kalkman
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of CY1107277T1 publication Critical patent/CY1107277T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Η παρούσα εφεύρεση αφορά σε νέους εστέρες λιπαρών οξέων της ανατρέψιμης ιλοπεριδόνης μεταβολίτης Ρ-88-8991, στην παρασκευή τους, στη χρήση τους ως φαρμακευτικές συνθέσεις που τους περιέχουν.
CY20081100126T 2003-10-01 2008-02-01 Βενζισοξαζολες CY1107277T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0322994.5A GB0322994D0 (en) 2003-10-01 2003-10-01 Organic compounds
EP04787069A EP1668003B1 (en) 2003-10-01 2004-09-30 Benzisoxazoles

Publications (1)

Publication Number Publication Date
CY1107277T1 true CY1107277T1 (el) 2012-11-21

Family

ID=29415309

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20081100126T CY1107277T1 (el) 2003-10-01 2008-02-01 Βενζισοξαζολες

Country Status (13)

Country Link
US (7) US20070197595A1 (el)
EP (1) EP1668003B1 (el)
JP (2) JP2007507455A (el)
AT (1) ATE378331T1 (el)
CY (1) CY1107277T1 (el)
DE (1) DE602004010161T2 (el)
DK (1) DK1668003T3 (el)
ES (1) ES2297493T3 (el)
GB (1) GB0322994D0 (el)
PL (1) PL1668003T3 (el)
PT (1) PT1668003E (el)
SI (1) SI1668003T1 (el)
WO (1) WO2005030763A1 (el)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0322994D0 (en) * 2003-10-01 2003-11-05 Novartis Ag Organic compounds
WO2012032532A1 (en) * 2010-09-07 2012-03-15 Symed Labs Limited "processes for the preparation of 4'-[3-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperidino]propoxy]-3'-methoxyacetophenone and intermediates thereof"
AU2013232014B2 (en) * 2012-03-14 2016-06-16 Vanda Pharmaceuticals Inc. An iloperidone metabolite for use in the treatment of psychiatric disorders

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4804663A (en) * 1985-03-27 1989-02-14 Janssen Pharmaceutica N.V. 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
US5994392A (en) * 1988-02-26 1999-11-30 Neuromedica, Inc. Antipsychotic prodrugs comprising an antipsychotic agent coupled to an unsaturated fatty acid
US5158952A (en) * 1988-11-07 1992-10-27 Janssen Pharmaceutica N.V. 3-[2-[4-(6-fluoro-1,2-benzisoxozol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9 tetrahydro-9-hydroxy-2-methyl-4H-pyrido [1,2-a]pyrimidin-4-one, compositions and method of use
US5776963A (en) * 1989-05-19 1998-07-07 Hoechst Marion Roussel, Inc. 3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility
US5364866A (en) * 1989-05-19 1994-11-15 Hoechst-Roussel Pharmaceuticals, Inc. Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analetics
EP0402644B1 (en) * 1989-05-19 1995-08-16 Hoechst-Roussel Pharmaceuticals Incorporated N-(aryloxyalkyl)heteroarylpiperidines and -heteroarylpiperazines,a process for their preparation and their use as medicaments
TW487572B (en) * 1996-05-20 2002-05-21 Janssen Pharmaceutica Nv Aqueous suspensions of 9-hydroxyrisperidone fatty acid esters
US5795909A (en) * 1996-05-22 1998-08-18 Neuromedica, Inc. DHA-pharmaceutical agent conjugates of taxanes
IL119095A (en) * 1996-08-19 2000-06-01 Mul T Lock Technologies Ltd Lock housing
US6225321B1 (en) * 1997-06-05 2001-05-01 Oliver Yoa-Pu Hu Long analgesic acting nalbuphine polyester derivative and method of use
UA72189C2 (uk) * 1997-11-17 2005-02-15 Янссен Фармацевтика Н.В. Фармацевтична композиція, що містить водну суспензію субмікронних ефірів 9-гідроксирисперидон жирних кислот
US5955459A (en) * 1997-11-26 1999-09-21 Neuromedica, Inc. Fatty acid-antipsychotic compositions and uses thereof
ATE556706T1 (de) * 2001-03-23 2012-05-15 Luitpold Pharm Inc Fettalkohol-arzneimittel-konjugate
JP2005504783A (ja) * 2001-08-31 2005-02-17 ノバルティス アクチエンゲゼルシャフト イロペリドン代謝産物の光学異性体
EP1551393A4 (en) * 2002-07-30 2010-06-16 Peter Migaly COMBINATION OF THERAPY FOR DEPRESSION, PREVENTION OF SUICIDE AND VARIOUS MEDICAL AND PSYCHIATRIC DISORDERS
GB0322994D0 (en) * 2003-10-01 2003-11-05 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
EP1668003B1 (en) 2007-11-14
JP5794667B2 (ja) 2015-10-14
DE602004010161D1 (de) 2007-12-27
PT1668003E (pt) 2007-12-31
US20070197595A1 (en) 2007-08-23
US20200131166A1 (en) 2020-04-30
JP2007507455A (ja) 2007-03-29
JP2011157377A (ja) 2011-08-18
DE602004010161T2 (de) 2008-10-30
US20170129878A1 (en) 2017-05-11
US20180118729A1 (en) 2018-05-03
PL1668003T3 (pl) 2008-05-30
EP1668003A1 (en) 2006-06-14
US20110172272A1 (en) 2011-07-14
ATE378331T1 (de) 2007-11-15
ES2297493T3 (es) 2008-05-01
WO2005030763A1 (en) 2005-04-07
DK1668003T3 (da) 2008-03-03
GB0322994D0 (en) 2003-11-05
US20190276444A1 (en) 2019-09-12
US20190055228A1 (en) 2019-02-21
SI1668003T1 (sl) 2008-04-30

Similar Documents

Publication Publication Date Title
EA201070699A1 (ru) Композиции 3-(6-(1-2,2-дифторбензо[d][1,3]диоксол-5-ил)циклопропанкарбоксамидо)-3-метилпиридин-2-ил)бензойной кислоты
EA201070698A1 (ru) Твердые формы 3-(6-(1-(2,2-дифторбензо[d][1,3]-диоксол-5-ил)циклопропанкарбоксамидо)-3-метилпиридин-2-ил)бензойной кислоты
NO20051102L (no) Sulfonylamino-eddiksyre-derivater
TW200716568A (en) 1H-quinazoline-2,4-diones
NO20073601L (no) Immunresponsmodifikator-skumformuleringer
DE602005021770D1 (de) Indol-1-yl-essigsäurederivate
TW200621729A (en) Pyrimidine derivatives
DE60334773D1 (de) Formulierungen zur oralen verabreichung von wirkstoffen
BRPI0515209A (pt) compostos, composição cosmética, usos de uma composição e composição farmacêutica
EA200702589A1 (ru) 2,6-хинолинильные производные, способы их получения и их применение
HN2003000044A (es) Esteres hidroxamato del acido n - (4-fenil sustituido)-antranilico.
TW200745122A (en) New compounds I
EA200701172A1 (ru) 2-алкокси-3,4,5-тригидроксиалкиламиды, их получение, композиции, их содержащие, и применение
SV2004001555A (es) Difenilazetidinonas cationicamente sustituidas, procesos para su preparacion, medicamentos que contienen estos compuestos y sus usos
HN2003000038A (es) Esteres hidroxamato de acido n-(4-fenil-sustituido)-antranilico
UY29999A1 (es) "n-pirazinil-fenilsulfonamidas, procedimientos y compuestos intemedios utilizados en su preparacion, composiciones farmaceuticas que las contienen y aplicaciones"
IN2011KN05169A (el)
WO2008152334A3 (fr) Nouveaux dérivés d'acide 3-phenyl acrylique activateurs des récepteurs de type ppar, leur méthode de préparation et leur utilisation dans des compositions cosmétiques ou pharmaceutiques
CY1107277T1 (el) Βενζισοξαζολες
WO2006110185A3 (en) Antiinfective lipopeptides
EA200801137A1 (ru) Соединения для ингибирования апоптоза
CY1111361T1 (el) Νεα προσδεματα συναγωνιστες των υποδοχεων rar, χρηση στην ανθρωπινη ιατρικη καθως και στην κοσμετολογια
WO2006103119A3 (en) Tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and also in cosmetics
GEP20125563B (en) 2-amino-2-phenylalkanol derivatives, preparation method thereof and pharmaceutical compositions containing same
EA200700191A1 (ru) Композиции, содержащие никорандил, способ получения и применение